NEW YORK (GenomeWeb) – DeNovo Sciences today announced a collaborative research agreement with South Texas Accelerated Research Therapeutics (START) to perform whole-genome sequencing on circulating tumor cells.

Under the terms of the agreement, START will collect blood from cancer patients and use DeNovo instruments and reagents for CTC enrichment and purification. The enriched CTCs will then be sent to a lab for whole-genome sequencing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.